Moderna starts Covid-19 vaccine trials for children

Moderna starts Covid-19 vaccine trials for children

Moderna on Tuesday said it has started its Covid-19 vaccine trials for children aged 6 months to under 12 years, with plans to enroll about 6,750 participants.“We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada,” said CEO Stephane Bancel in a statement.“This pediatric study will help us assess the potential safety and immunogenicity of our Covid-19 vaccine candidate in this important younger age population.”Comments Read Next6 hours agoUK adds 2 more Gulf countries to COVID-19 ‘red list'7 hours agoIndia widens coronavirus curbs as infections increase1 day agoSaudi denies halting use of AstraZeneca vaccine1 day agoBahrain to climb Mt. Everest, donate 2,000 doses of vaccines to Nepal2 days agoBahrain records 579 new cases, 501 recoveries2 days agoSaudi Arabia administered over 2 million doses of Covid-19 vaccine3 days agoKuwait records 1,211 new Covid-19 cases, 9 deaths3 days agoBahrain: Family gatherings main reason for rise in Covid-19 cases3 days agoBahrain: UOB continues distance learning, exception to certain courses3 days agoBahrain: F1 drivers Perez, Sainz take Covid-19 vaccine